Anti‐IL‐4Rα mAb (dupilumab) vs placebo (on top of topical steroids)
Disease‐specific quality of life · patients with severe chronic rhinosinusitis with nasal polyps
1 finding from 1 review
- no estimate extracted3 studies · 784 participantsHigh
The review found no eligible studies for this question.
The review found no eligible studies for this question.